Enrofloxacin + Silver Sulfadiazine
455 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
455
Total Reports
14
Deaths Reported
310.0%
Death Rate
Active Ingredients
EnrofloxacinEnrofloxacin + Silver SulfadiazineSilver Sulfadiazine
Administration Routes
UnknownAuricular (Otic)TopicalOralOphthalmicIntraocularIntra-ArticularOther
Species Affected
Dog 216
Unknown 175
Cat 48
Rabbit 7
Human 6
Guinea Pig 1
Rat 1
Cockatiel 1
Most Affected Breeds
Unknown 184
Retriever - Labrador 24
Domestic Shorthair 24
Crossbred Canine/dog 12
Terrier - Yorkshire 12
Retriever - Golden 10
Pug 9
Shih Tzu 8
Chihuahua 7
Cat (unknown) 7
Most Reported Reactions
Applicator, Abnormal 40
Lack of efficacy - NOS 34
Uncoded sign 25
Containers, Leaking 25
Ear discharge 24
Deafness 22
Dispenser, Abnormal 22
Other abnormal test result NOS 21
Vomiting 20
Behavioural disorder NOS 19
Loss of hearing 19
Pinnal erythema 17
Outcome Breakdown
Outcome Unknown
138 (49.3%)
Recovered/Normal
79 (28.2%)
Ongoing
47 (16.8%)
Euthanized
9 (3.2%)
Died
5 (1.8%)
Recovered with Sequela
2 (0.7%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.